JasonAIncorvatiMD
Oncology • Philadelphia, PABreast Cancer, Hematologic Oncology
Assistant Professor, Temple University
Dr. Incorvati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-2500Fax+1 215-728-3639
Summary
- Dr. Jason Incorvati is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Fox Chase Cancer Center-American Oncologic Hospital and Suburban Community Hospital. He received his medical degree from Temple University School of Medicine and has been in practice 8 years. He specializes in breast cancer and hematologic oncology and is experienced in breast cancer, hematologic oncology--lymphoma, myeloma, myelodysplasia, and benign hematology.
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2012 - 2015
University of MarylandResidency, Internal Medicine, 2009 - 2012
Lewis Katz School of Medicine at Temple UniversityClass of 2009
Certifications & Licensure
NJ State Medical License 2015 - 2025
PA State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 59 citationsTargeted therapy for HER2 positive breast cancerJason A. Incorvati, Shilpan S. Shah, Ying Mu, Janice Lu
Journal of Hematology & Oncology. 2013-06-03 - YIA24-002: Patients' Perspectives on Being Treated by Multiple Care Teams for Autologous Transplant/CAR-T Eligible Lymphoma and Multiple Myeloma.Zachary A K Frosch, Clark Meshack, Caitlin Meeker, Asya Varshavsky-Yanovsky, Rashmi Khanal
Journal of the National Comprehensive Cancer Network. 2024-04-05 - ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, Sofia F Garcia, Fei Shen
Journal of Clinical Oncology. 2024-08-20
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
